Literature DB >> 18386456

Cervical screening in Hungary: why does the "English model" work but the "Hungarian model" does not?

A Kovács, L Döbrossy, A Budai, I Boncz, A Cornides.   

Abstract

A comparison has been made between the English practice and the "Hungarian model" of cervical screening. In England, until 1986, extensive opportunistic screening was the practice, but--as it had no effect on cervical cancer mortality--afterwards, the screening policy was changed to be strictly in line with international recommendations. On the other hand, in Hungary, the "old practice" has been petrified: gynaecologists are the "gatekeepers", a "gynaecological examination completed with smear-taking for cytology" makes up the screening strategy. Although in the frame of a National Public Health Programme all the prerequisites for nationwide organised screening have been provided, and an up-to-date screening strategy declared, 20-times as many smears are taken and analysed outside as inside the programme, and the efforts have had no impact on cervical cancer mortality. This is because "old habits die hard". There is an urgent need to reconsider the screening strategy, and to reorganise the cervical screening practice in Hungary.

Entities:  

Mesh:

Year:  2008        PMID: 18386456

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

Review 1.  Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries.

Authors:  Márta Péntek; Gyula Poór; Piotr Wiland; Martina Olejárová; Marek Brzosko; Catalin Codreanu; Nóra Brodszky; László Gulácsi
Journal:  Eur J Health Econ       Date:  2014-05-16

2.  The disease burden of colorectal cancer in Hungary.

Authors:  Imre Boncz; Valentin Brodszky; Márta Péntek; István Agoston; Zsolt Nagy; Krisztián Kárpáti; Ildikó Kriszbacher; Péter Fuszek; László Gulácsi
Journal:  Eur J Health Econ       Date:  2010-01

3.  Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective.

Authors:  Márta Péntek; Bernadette Rojkovich; László Czirják; Pál Géher; Péter Keszthelyi; Attila Kovács; László Kovács; Zita Szabó; Zoltán Szekanecz; László Tamási; Ágnes Edit Tóth; Ilona Ujfalussy; Noémi Vártokné Hevér; Bálint Strbák; Petra Baji; Valentin Brodszky; László Gulácsi
Journal:  Eur J Health Econ       Date:  2014-05-16

4.  Clinical and health policy experiences with HPV prevalence within the Hungarian organized cervical cancer screening program.

Authors:  Réka Vajda; Krisztina Juhász; Dóra Endrei
Journal:  J Gynecol Oncol       Date:  2018-03-01       Impact factor: 4.401

5.  Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary.

Authors:  Zoltán Vokó; László Nagyjánosi; Zoltán Kaló
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295

6.  General practitioners can increase participation in cervical cancer screening - a model program in Hungary.

Authors:  Anikó Gyulai; Attila Nagy; Vera Pataki; Dóra Tonté; Róza Ádány; Zoltán Vokó
Journal:  BMC Fam Pract       Date:  2018-05-19       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.